The success of Viagra initially drove a surge for pharma, however recent shifts present a murky outlook for investors. Generic competitors are eroding earnings, and continued litigation add further difficulty to the https://phoenixhdyp823781.wizzardsblog.com/41129592/viagra-and-pharma-a-precarious-play